A Form 4 filed on September 15, 2026 discloses that Lu Peng, President of Pharvaris N.V. (NASDAQ:PHVS), executed a series of transactions between September 11 and September 14, 2026, including a stock option exercise, open-market sales, and shares withheld for tax obligations.

Key Highlights

  • Option exercise: Lu Peng exercised stock options covering 15,000 shares of Common Stock on September 11, 2026, at an exercise price of $2.59 per share.
  • Shares sold: 15,000 shares were sold on September 11, 2026, at a weighted average price of $40.1298, with individual sale prices ranging from $40.00 to $40.30.
  • 10b5-1 plan: According to the filing, the exercise and sale were "a scheduled exercise and sale from 10b5-1 trading plan."
  • Tax withholding: 109 shares were withheld on September 11, 2026, at $37.51 per share, and 117 shares were withheld on September 14, 2026, at $38.02 per share, both to satisfy tax withholding obligations upon the vesting of restricted stock units.
  • Resulting ownership: Following all reported transactions, Peng directly beneficially owned 64,953 shares of Common Stock.
  • Remaining options: After the exercise, Peng held 13,308 stock options (right to buy) at $2.59 per share, with an expiration date of February 3, 2030.

Transaction Details for Pharvaris President Lu Peng's September 2026 Filings

According to the Form 4 filed with the SEC, Lu Peng, identified as President of Pharvaris N.V., carried out multiple transactions in the company's Common Stock across two trading days. On September 11, 2026, Peng exercised stock options for 15,000 shares at a conversion price of $2.59 per share, increasing beneficially owned shares to 80,179. Those 15,000 shares were then sold in a cashless exercise transaction at a weighted average price of $40.1298, reducing direct ownership to 65,179 shares.

Also on September 11, 2026, the filing reports that 109 shares were withheld by the issuer at $37.51 per share to cover tax obligations tied to the vesting of restricted stock units, bringing the total to 65,070 shares. On September 14, 2026, an additional 117 shares were withheld at $38.02 per share for the same purpose, leaving a final directly held balance of 64,953 shares. The filing notes that the option being exercised originally vested 25% on February 3, 2021, with the remainder vesting in 1/48 monthly installments thereafter.

The filing was signed by Marnus Nel as Attorney-in-Fact for Peng Lu, and the box indicating a transaction made pursuant to a Rule 10b5-1(c) plan was checked. The filing notes that full information on the number of shares sold at each separate price will be provided upon request to the issuer, any security holder, or the SEC staff.

What Was Disclosed

Pharvaris N.V. President Lu Peng disclosed a 10b5-1 plan option exercise and sale of 15,000 shares, along with tax-related share withholdings on two dates, resulting in direct beneficial ownership of 64,953 Common Stock shares as of September 14, 2026.